SEC 13F Intelligence

Boxer Capital, LLC / FULC

Boxer Capital, LLC’s Fulcrum Therapeutics Inc Position

Does Boxer Capital, LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 1.25M shares worth $35M in Q3 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$35M
Q3 2021
Shares
1.25M
% of Portfolio
+1.23%
Quarters Held
3
position exited

Position History FULC

Reported value by quarter
Q2 ’20: $13MQ2 ’20Q3 ’20: $6MQ3 ’20Q3 ’21: $35MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20211.25M$35M+1.23%
Q3 2020705.9K$6M+0.19%
Q2 2020705.9K$13M+0.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of FULC.